Search
Vanda Pharmaceuticals Inc
VNDAAdd to Watchlist
5.800USD
-0.160-2.68%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
348.78MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Fanapt
117.30M
54.28%
Hetlioz
71.43M
33.05%
PONVORY
27.37M
12.67%
By RegionUSD
Name
Revenue
Proportion
United States
216.10M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Fanapt
117.30M
54.28%
Hetlioz
71.43M
33.05%
PONVORY
27.37M
12.67%
